YCS19· AIArpeggio Bio
Arpeggio Bio develops drugs targeting transcription factors using AI…
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Algen BiotechnologiesW20Using CRISPR to find treatments for cancer and inflammationShared: biotech, drug discoveryActive
Altay TherapeuticsW20Altay develops disease-modifying therapies targeting transcription…Shared: biotech, drug discoveryActive
Harmonic DiscoveryS21Multi-targeted therapeutics to treat complex diseasesShared: biotech, drug discoveryActive
Parallel BioS21Using the immune system to cure diseaseShared: biotechActive
Adjacent
Overlapping tags, a different niche.
Talus BioS21Discovering drugs that target the DNA regulomeShared: biotech, genomics, drug discoveryActive
Anto BiosciencesF25A Foundation Model for Microbial Communities.Shared: biotech, genomics, drug discoveryActive
Sequence BioS19Discovering the true signals of disease to power life-changing drugs.Shared: genomics, drug discoveryActive
Ochre BioW20RNA medicines for liver diseasesShared: biotech, genomicsActive
InvitrisW23Creating new protein-based drugs at scaleShared: biotech, drug discoveryActive
Also from S19 in AI
Batchmates in Summer 2019.
GEn1E LifesciencesS19AI platform accelerating therapies for rare & inflammatory diseases.Active
AudioFocusS19Hearing aids that work in noisy places, like restaurants, using ML.Inactive
BeaconsS19An AI-powered, all-in-one business platform for content creatorsActive
CoLabS19Human and AI design review for hardwareActive
DashblockS19Turn any website into an APIInactive
DeepnoteS19A better data science notebook.Active
About Arpeggio Bio
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.
Boulder, CO, USA
Arpeggio Bio: questions
Which YC batch was Arpeggio Bio in?
Arpeggio Bio was in Y Combinator's Summer 2019 batch (S19).
Is Arpeggio Bio still active?
Y Combinator lists Arpeggio Bio as active.
Where is Arpeggio Bio based?
Arpeggio Bio lists Boulder, CO, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.